alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 3160 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 3160

      To extend the temporary suspension of duty on Spiromesifen.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 10, 2012

  Mrs. Hagan introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
      To extend the temporary suspension of duty on Spiromesifen.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SPIROMESIFEN.

    (a) In General.--Heading 9902.10.71 of the Harmonized Tariff 
Schedule of the United States (relating to Spiromesifen) is amended by 
striking the date in the effective period column and inserting ``12/31/
2015''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
**Exhibit 4.12**

***Convenience Translation from theGerman Original***

**KIM SCHINDELHAUER**

Chairman of theSupervisory board of

AIXTRON AG

MrSteve PerryThe Board, AIXTRON AGKackertstr. 15-17

D-52072Aachen

Date May 11, 2004

**Boardservice contracts — regulation on profit-sharing bonus**

DearMr Perry

Asalready advised, I am pleased to confirm once again in writing the resolutionof the Supervisory Board concerning the regulation on the profit-sharing bonusagreed with you.

Forthe financial year 2004, s. 4 no. 2 of the board service contract will beamended to the effect that:

1.               8%(previously 2%) of the consolidated profit for the year shall be made availableto the full board as the bonus pot;

2.               theconsolidated profit for the 2004 financial year will not be reduced by anylosses brought forward from previous years;

3.               theaggregate amount of the bonus pot is limited to in total €1.0 million.

Allother regulations remain unchanged.

Yourssincerely

[signed]K. Schindelhauer

----
BROWARD R.V. INC., and Gigi Stetler, Appellants, v. 4700, LLC, a Florida limited Liability Company, Appellee.

No. 4D16-3696

District Court of Appeal of Florida, Fourth District.

[January 25, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Darryl ORTIZ-CABERERA, DOC# S39285, Appellant, v. STATE of Florida, Appellee.

Case No. 2D16-2197

District Court of Appeal of Florida, Second District.

Opinion filed January 26, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Robert WILLIAMS, Appellant, v. Wells FARGO; Sedgwick CMS, Appellees.

No. 1D17-4435

District Court of Appeal of Florida, First District.

June 5, 2018

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
This section of the FEDERAL REGISTER

contains editorial corrections of previously

published Presidential, Rule, Proposed Rule,

and Notice documents. These corrections are

prepared by the Office of the Federal

Register. Agency prepared corrections are

issued as signed documents and appear in

the appropriate document categories

elsewhere in the issue.

Corrections Federal Register

23295

Vol. 62, No. 82

Tuesday, April 29, 1997

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

14 CFR Part 187

[Docket No. 28860; Amendment No. 187-

7]

RIN 2120-AG17

Fees for Air Traffic Services for Certain

Flights Through U.S.-Controlled

Airspace

Correction

In rule document 97–6980 beginning

on page 13496 in the issue of Thursday,

March 20, 1997 make the following

corrections:

1. On page 13496, in the second

column, fourth paragraph beginning in

the second line ‘‘[Insert date 120 after

the date of publication]’’ should read

‘‘July 18, 1997’’.

2. On page 13499, in the first column,

second paragraph in the 7th line, ‘‘offer’’

should read ‘‘defer’’.

§ 187.15 [Corrected]

3. On page 13503, in the first column,

in § 187.15(d), in the second line

‘‘party’’ should read ‘‘part’’.

BILLING CODE 1505-01-D
[Federal Register Volume 61, Number 64 (Tuesday, April 2, 1996)]
[Corrections]
[Page 14596]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: X96-50402]



-----------------------------------------------------------------------

DEPARTMENT OF VETERANS AFFAIRS

38 CFR Part 1

RIN 2900-AH84


Rulemaking Procedures

Correction

    In rule document 96-6496 appearing on page 11309 in the issue of 
Wednesday, March 20, 1996 make the following correction:


Sec. 1.551  [Corrected]

    In the third column, the section heading should read as set forth 
above.

BILLING CODE 1505-01-D
```
[Federal Register Volume 60, Number 9 (Friday, January 13, 1995)]
[Notices]
[Page 3298]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: X95-60113]

-----------------------------------------------------------------------
```
**EXHIBIT 32.1**

** **

##### **CERTIFICATION**

##### ** **

Pursuant to the requirements setforth in Rule 13a-14(b) of the Securities Exchange Act of 1934, asamended (the “Exchange Act”), and Section 1350 of Chapter 63 ofTitle 18 of the United States Code (18 U.S.C. § 1350), I, MichaelE. Hart, the President, Chief Executive Officer and Chief Financial Officer ofAllos Therapeutics, Inc. (the “Company”), hereby certify that, to the best ofmy knowledge:

 

1.               TheCompany’s Quarterly Report on Form 10-Q for the period ended March 31, 2004, to which this Certification isattached as Exhibit 32.01 (the “Quarterly Report”), fully complies with therequirements of Section 13(a) or Section 15(d) of the Exchange Act; and

 

2.               Theinformation contained in the Quarterly Report fairly presents, in all materialrespects, the financial condition and results of operations of the Company.

 

Dated: May 10, 2004

 
|   | /s/ Michael E. Hart                                                                                                              |
|--------|----------------------------------------------------------------------------------------------------------------------------------|
|   | Michael E. Hart                                                                                                                  |
|   | President, Chief Executive  Officer and  Chief Financial Officer  (Principal Executive Officer and  Principal Financial Officer) |

 

A signed original of this written statementhas been provided to Allos Therapeutics, Inc. and will be retained by AllosTherapeutics, Inc. and furnished to the SEC or its Staff upon request. Thiscertification “accompanies” the Form 10-Q to which it relates, is not deemed filed withthe SEC and is not to be incorporated by reference into any filing of theCompany under the Securities Act of 1933, as amended, or the SecuritiesExchange Act of 1934, as amended (whether made before or after the date of theForm 10-Q), irrespective of anygeneral incorporation language contained in such filing

 

1

----
## Breadcrumb

-  Publications 
-  Articles 

#           On the reported optical activity of amino acids in the Murchison meteorite      

      January 1, 1983    

In analyses of extracts from the Murchison meteorite (a carbonaceous chondrite), Engel and Nagy1 reported an excess of L-enantiomers for several protein amino acids but found that the non-protein amino acids were racemic. They suggested that the excess of L-isomers might have resulted from an asymmetric synthesis or decomposition. Their results disagree with those obtained previously2-4 and they claim this is due to improved methodology. In fact, their extraction method and analytical procedure (gas chromatography-mass spectrometry, GC-MS) was similar to those used in the original report2 of amino acids in the Murchison meteorite except that they used specific ion monitoring in the GC-MS measurements. We found the results of Engel and Nagy odd in that likely contaminants (the protein amino acids ala, leu, glu, asp and pro) were nonracemic while unlikely contaminants (isovaline and ??-amino-n-butyric acid) were racemic. For example, Engel and Nagy report that the leucine is ???90% L-enantiomer in the water-extracted sample whereas isovaline (??-methyl-??-aminobutyric acid) is racemic. It would be most unusual for an abiotic stereoselective decomposition or synthesis of amino acids to occur with protein amino acids but not with non-protein amino acids. We now show here that the explanation of terrestrial contamination is consistent with their results and is much more probable. ?? 1983 Nature Publishing Group.

## Citation Information
I 

114TH CONGRESS 

2D SESSION H. R. 4953 

To amend title 5, United States Code, to limit the length of administrative 

leave for Federal employees to 30 days, and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 14, 2016 

Mr. SALMON introduced the following bill; which was referred to the 

Committee on Oversight and Government Reform 

A BILL 

To amend title 5, United States Code, to limit the length 

of administrative leave for Federal employees to 30 days, 

and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘No Work, No Pay Act 

5 of 2016’’. 

6 SEC. 2. LIMITATION ON ADMINISTRATIVE LEAVE. 

7 (a) IN GENERAL.—Subchapter II of chapter 63 of 

8 title 5, United States Code, is amended by adding at the 

9 end the following: 


sradovich on DSK3TPTVN1PROD with BILLS
2 

•HR 4953 IH

1 ‘‘§ 6330. Limitation on administrative leave 

2 ‘‘(a) IN GENERAL.—Except as provided in subsection 

3 (b), an employee may not be placed on administrative 

4 leave, or any other paid non-duty status without charge 

5 to leave, for more than 30 consecutive days for reasons 

6 relating to misconduct or performance. 

7 ‘‘(b) EXTENSION FOR INVESTIGATION.—In the case 

8 of an employee placed on administrative leave pending an 

9 investigation, the head of an agency may grant an exten10 sion of administrative leave for additional periods of not 

11 more than 30 consecutive days each only if the office in12 vestigating the employee submits a report to Congress and 

13 the head of the applicable agency containing a certification 

14 that additional time is needed to complete such investiga15 tion, including the reasons for the need for additional 

16 time.’’. 

17 (b) CLERICAL AMENDMENT.—The table of sections 

18 for subchapter II of chapter 63 of title 5, United States 

19 Code, is amended by adding after the item relating to sec20 tion 6329 the following new item: 

‘‘6330. Limitation on administrative leave.’’. 

Æ 


sradovich on DSK3TPTVN1PROD with BILLS
EX-4.10



 EXHIBIT 4.10 

July 24, 2017 
 Securities and Exchange
Commission 
 100 F Street, NE 
 Washington, D.C. 20549 

 

	 	Re:	 Worthington Industries, Inc. – Annual Report on Form 10-K for the fiscal year ended May 31, 2017



 - SEC File No. 1-8399 

Ladies and Gentlemen: 

Worthington Industries, Inc., an Ohio corporation, is today filing its Annual Report on Form 10-K for the fiscal year ended
May 31, 2017 (the “Form 10-K”). 
 None of (i) Worthington Industries, Inc., (ii) any of the
consolidated subsidiaries of Worthington Industries, Inc. or (iii) Worthington Armstrong Venture, a 50%-owned unconsolidated joint venture (in the form of a general partnership between Armstrong Ventures, Inc., a subsidiary of Armstrong World
Industries, Inc., and The Worthington Steel Company (Delaware), a subsidiary of Worthington Industries, Inc.), for which financial statements are required to be filed with the Form 10-K, has outstanding any instrument or agreement with respect to
its long-term debt, other than those filed or incorporated by reference as an exhibit to the Form 10-K, under which the total amount of long-term debt authorized exceeds 10% of the total assets of Worthington Industries, Inc. and its subsidiaries on
a consolidated basis. In accordance with the provisions of Item 601(b)(4)(iii) of SEC Regulation S-K, Worthington Industries, Inc. hereby agrees to furnish to the SEC, upon request, a copy of each instrument or agreement defining (i) the
rights of holders of the long-term debt of Worthington Industries, Inc. or (ii) the rights of holders of the long-term debt of a consolidated subsidiary of Worthington Industries, Inc. or (iii) the rights of holders of the long-term debt
of Worthington Armstrong Venture, in each case which is not being filed or incorporated by reference as an exhibit to the Form 10-K. 
  

	
	 Very truly yours,

	
	 WORTHINGTON INDUSTRIES, INC.

	
	 /s/ B. Andrew Rose

	 B. Andrew Rose

	 Executive Vice President and Chief Financial Officer
James H. SCHARFSCHWERDT, Appellant, v. R.J. LARIZZA, State Attorney, Seventh Judicial Circuit, Office of the State Attorney, St. Johns County, Florida and State of Florida, Appellees.

Case No. 5D17-2590

District Court of Appeal of Florida, Fifth District.

Decision filed June 26, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
The undersigned court-appointed Mortgage Modification Mediation Mediator, reports

to the court as follows:

A. The final Mortgage Modification Mediation Mediator (MMM) conference was conducted on

01-13-2021 and the following parties were present:

1. [ ] The Debtor:

2. [ ] The Debtor's Attorney:

3. [ ] The Lender's Representative:

4. [ ] The Lender's Attorney:

B. The final MMM conference was scheduled for 01-13-2021 but not conducted for the

following reason:

1. [ ] The parties settled prior to attending

2. [ ] The case was dismissed

3. [ ] The debtor failed to attend

4. [ ] The debtor's attorney failed to attend

5. [ ] The lender failed to attend

6. [ ] The lender's attorney failed to attend

7. [ x ] Other: unrepresented borrower's hostility toward mediator making continued

interaction infeasible.

C. The result of the MMM conference is as follows:

1. [ ] The parties reached an agreement

2. [ ] The parties did not reach an agreement

UNITED STATES BANKRUPTCY COURT

SOUTHERN DISTRICT OF FLORIDA

www.flsb.uscourts.gov

In Re: Case #19-24331

Debtor: Ralph Sanders Chapter 13

FINAL REPORT OF LOSS MITIGATION MEDIATOR

Dated: 01.04.21 Signature of Mediator: //s// Christian McCue

Printed Name: Christian McCue

Address: 6245 N Federal Hwy # 418 Ft. Lauderdale ,

FL 33308

Copies To: Phone: (954) 267-9377

[All Parties to Mediation] Email: christian.mccue@mccuelaw.com

Case 19-24331-PDR Doc 93 Filed 01/04/21 Page 1 of 1
UNITED STATES ENVIRONMENTAL PROTECTION AGENCY WASHINGTON, D.C. 20460 Lynne Oreschnigg Regu l atory Compliance Specialist Huntsman Corporation 10003 Woodloch Forest Drive, The Woodlands, Texas 77380 

### [) F C 1 r- ·,, ) ·r - , 0 L U I ]

Re: Request for extension to submit final reports for developm ental toxicity studies for 2- 0xiranemethanami ne, N - [ 4 - (2-ox irany lmethoxy) phenyl ]-N - (2-oxiranylmethyl) - (CASRN 5026 - 74-4). Dear Ms. Oreschnigg: EPA has rece i ved your December 11, 2015, submission on behalf of Huntsman Corporation (Huntsman) requesting an extension of time to submit fina l reports for developmental toxicity studies for the chemical substance 2-0xiranemethanamin e, N - [4-(2-oxiranylmethoxy) phenyl]- N - (2-ox iranylmethyl)- (CASRN 5026-74-4) . These studies were required pursuant to a test rule issued by EPA under section 4 ofthe Toxic Substances Control Act on October 21,20 1 1 (76 FR 65385) (HPV3) . Huntsman previously submitted protocols for definitive testing fo r developmental and reprod u ctive effects on November 17, 2014. In its submissi on , Hu ntsman also i ndicated tha t s ince these defini t ive tests were lengthier and more complex than the screening level tests set forth in the test rule, and requi red longer deadlines for fina l reporting, th ey would need additional time to submit the final reports. The submitted st udy plans and protocols underwent extensive review and were approved by EPA, with comments rec eived and noted by Huntsman (Final Data Adeq u acy Review dated December 23 , 201 5) . EPA also approved the additional time needed to conduct th i s testing. Huntsman later submitted to EPA a proposal to use a commercial grade of the test substance for the testi ng. EPA indicated that it was w illi ng to consider use of the commercial grade, but requi red that Huntsman perform a detailed analytical analysis befo re app roval. As noted in your request for an extension, both the analysis and E PA 's rev iew (and subsequent approval ofthe use of the commercial substance) required additional t i me, resu lting in the need for an additional extension of time for the devel opmental toxicity studi es. As noted i n your request, Huntsman still anticipates the required reproductive effects testing to be completed as scheduled . EPA is granting the requested extens i on to submit the final reports for the developmental studies, as fo ll ows: 1) preliminary developmental tox i c ity testing (OECD 414) , June 30 , 2016; and 2) definitive developmental tox i city testing (OECD 414) , November 30 , 2016.

I nternet Address (URL) • http'/fwww epa . gov Recycled/Recyclable • Pri nted w i th Vegetable Oil Based Inks on 100% Postconsumer. Process Chlorine Free Recycled PaperThe due date for the definitive two-generation reproductive effects testing (OECD 416) remains August 31,2017. If you have any questions, please contact John Schaeffer by phone, (202) 564-8173 or email, schaeffer.john@epa.gov. cc: Docket EPA-HQ-OPPT-2009-0112

7'celreV 7 d **l~L4--Z__** Lorai e Passe Chief Chemical Information and Testing Branch
Asbel Perez VICIEDO and Carlos Renda, Appellants, v. CREAL DALLAS, LLC, Appellee.

No. 4D17-3812

District Court of Appeal of Florida, Fourth District.

[June 28, 2018]

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
* Pursuant to 5TH CIR. R. 47.5, the court has determined

that this opinion should not be published and is not precedent

except under the limited circumstances set forth in 5TH CIR.

R. 47.5.4.

IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

 

No. 97-50577

Conference Calendar

 

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

versus

RAFAEL SALAZAR-NAVARRO,

Defendant-Appellant.

- - - - - - - - - -

Appeal from the United States District Court

for the Western District of Texas

USDC No. SA-96-CR-331

- - - - - - - - - -

December 10, 1997

Before BARKSDALE, BENAVIDES, and STEWART, Circuit Judges.

PER CURIAM:*

Rafael Salazar-Navarro appeals from his sentence for illegal

reentry into the United States after his deportation in violation

of 8 U.S.C. § 1326. His motion for a stay of his appeal pending

the Supreme Court’s decision in United States v. AlmendarezTorres, 113 F.3d 515 (5th Cir. 1996), cert. granted, 117 S. Ct.

1333 (1997), is DENIED. 

Salazar-Navarro argues that he was charged with and pleaded

guilty to illegal reentry under § 1326(a) and that he could not
No. 97-50577

-2-

be sentenced under § 1326(b)(2) because the indictment failed to

allege that he had a prior aggravated felony conviction. His

argument is foreclosed by this court’s opinion in United States

v. Vasquez-Olvera, 999 F.2d 943, 946-47 (5th Cir. 1993).

AFFIRMED.
00451914.DOCX 

UNITED STATES BANKRUPTCY COURT

SOUTHERN DISTRICT OF FLORIDA

FT. LAUDERDALE DIVISION

In re:

BARBARA CALLE

SSN: XXX-XX-3589

Debtor.

Case No.: 20-12244-SMG

Chapter 7

______________________________/

ORDER SUSTAINING TRUSTEE, SCOTT N. BROWN’S 

OBJECTION TO CLAIM NO. 4

THIS CAUSE having come before the Court upon Trustee, Scott N. Brown’s Objection 

to Claim No. 4 of ACAR Leasing LTD., filed on September 2, 2020 (ECF No. 37)(the “Objection”) 

and the Court, having been advised by the Trustee through the submission of the instant order that: 

(i) the Objection was served on claimant required by Local Rule 3007-1(D); (ii) the 30-day 

response time provided by that rule has expired; and (iii) no one has filed, or served on the Trustee, 

Scott M. Grossman, Judge

_____________________________________________________________________________ United States Bankruptcy Court

ORDERED in the Southern District of Florida on October 13, 2020.

Case 20-12244-SMG Doc 42 Filed 10/13/20 Page 1 of 2
Case No. 20-12244-SMG

00451914.DOCX 

a response to the Objection; having reviewed the Objection, and the Court file; having considered 

the basis for the Objection; and being otherwise fully advised in the premises, it is

ORDERED as follows:

1. The Trustee’s objection to Claim No. 4 filed by ACAR Leasing LTD. is sustained. 

2. Claim No. 4 is stricken and disallowed.

###

Submitted by:

Scott N. Brown, Trustee

SunTrust International Center

One Southeast Third Avenue, Suite 1400

Miami, Florida 33131

Telephone: 305.379.7904

Facsimile: 305.379.7905

Email:sbrown@bastamron.com 

Copy furnished to:

Scott N. Brown, Trustee

Trustee Scott N. Brown is hereby directed to serve a copy of this Order immediately upon receipt on all interested 

parties and file a Certificate of Service.

Case 20-12244-SMG Doc 42 Filed 10/13/20 Page 2 of 2
EXHIBIT 99.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report on Form 10-QSB for the three-month
period ended March 31, 2003 of MNS Eagle Equity Group, Inc., a Nevada
corporation (the "Company"), as filed with the Securities and Exchange
Commission on the date hereof (the "Quarterly Report"), I, Stephen M. Siedow,
Chief Executive Officer and Chief Financial Officer of the Company certify,
pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

     1.   The Quarterly Report fully complies with the requirements of Section
          13(a) or 15(d) of the Securities and Exchange Act of 1934, as amended;
          and

     2.   The information contained in this Quarterly Report fairly presents, in
          all material respects, the financial condition and results of
          operation of the Company.

Date:  May 5, 2003


                                         /s/ Stephen M. Siedow
                                         ---------------------------------------
                                         Stephen M. Siedow, Chief Executive
                                         Officer and Chief Financial Officer
Benjamin BROWN, Appellant, v. STATE of Florida, Appellee.

Case No. 5D18-1076

District Court of Appeal of Florida, Fifth District.

Decision filed June 26, 2018

**DECISION WITHOUT PUBLISHED OPINION**

AFFIRMED.
[Federal Register Volume 61, Number 24 (Monday, February 5, 1996)]
[Corrections]
[Page 4302]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: X96-30205]



-----------------------------------------------------------------------

FEDERAL ELECTION COMMISSION

11 CFR Parts 100, 102, 109, 110 and 114

[Notice 1995-23]


Corporate and Labor Organization Activity; Express Advocacy and 
Coordination With Candidates

Correction

    In rule document 95-30381 beginning on page 64260 in the issue of 
Thursday, December 14, 1995, make the following corrections:
    1. On page 64261, in the 3rd column, in the 1st full paragraph, in 
the 14th line from the bottom, ``favorably'' should read 
``unfavorably''.
    2. On page 64267, in the first column, in the third full paragraph, 
in the seventh line from the bottom, ``driver'' should read ``drive''.
    3. On page 64268, in the second column, in the second full 
paragraph, in the fifth line from the bottom, ``even'' should read 
``event''.

PART 110--[CORRECTED]

    4. On page 64273, in the second column, in the Authority citation 
to Part 110, in the second line, ``438(a)(98)'' should read 
``438(a)(8)''.

BILLING CODE 1505-01-D